Dornase Alfa Administered to Patients With COVID-19 (DACOVID)
Clinical trial NCT04387786 · COMPLETED
Trial details
- NCT number
- NCT04387786
- Sponsor
- Feinstein Institute for Medical Research
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-03-31
- Primary completion
- 2020-04-24
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.